# Rituximab in Pretreated Elderly or Unfit B-CLL Patients

> **NCT01576588** · PHASE2 · COMPLETED · sponsor: **Prof. Dr. Med. Laimonas Griskevicius** · enrollment: 25 (actual)

## Conditions studied

- B-Cell Chronic Lymphocytic Leukemia

## Interventions

- **DRUG:** Rituximab
- **DRUG:** Glucocorticoid

## Key facts

- **NCT ID:** NCT01576588
- **Lead sponsor:** Prof. Dr. Med. Laimonas Griskevicius
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2011-10
- **Primary completion:** 2016-01
- **Final completion:** 2019-06
- **Target enrollment:** 25 (ACTUAL)
- **Last updated:** 2019-12-27


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01576588

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01576588, "Rituximab in Pretreated Elderly or Unfit B-CLL Patients". Retrieved via AI Analytics 2026-07-26 from https://api.ai-analytics.org/clinical/NCT01576588. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*